Continuous Versus Routine EEG in Critically Ill Patients Without Primary Neurologic Condition: Analysis of a Randomized Controlled Trial.
Eur J NeurolSep 29, 2026
Gregory Lepeu, Jan Novy, Vincent Alvarez et al.
✦ AI-curated · Sources linked
In 30 seconds
This post hoc analysis of the multicenter randomized CERTA trial evaluated the effectiveness of continuous EEG (cEEG) versus routine EEG (rEEG) in critically ill patients without primary neurologic conditions. Among 76 patients analyzed, cEEG did not show a significant difference in six-month mortality (p = 0.970) or functional outcomes compared to rEEG, indicating no measurable benefits from cEEG in this population.
Key findings
- cEEG was not associated with six-month mortality (p = 0.970).
- No significant difference in functional outcomes (CPC 1-2; p = 0.893) between cEEG and rEEG.
- No seizures or status epilepticus were detected in either group.
- Rates of EEG periodic patterns and medication changes were comparable between groups.
Why it matters
The findings suggest that in critically ill patients without primary neurologic conditions, cEEG may not provide additional clinical benefits over routine EEG, which could influence resource allocation in critical care settings.